Inhibition of plasminogen activators or matrix metalloproteinases prevents caediac rupture but impairs therapeitic angiogenesis and causes cardiac failure.
Heymans S., Luttun A., Nuyens D., Theilmeier G., Creemers E., Moons L., Dyspersin G.D., Cleutjens J.P.M., Shipley M., Angelillo A., Levi M., Nüsse O., Baker A., Keshet E., Lupu F., Herbert J.-M., Smits J.F.M., Shapiro S.D., Baes M., Borgers M., Collen D., Daemen M.J.A.P., Carmeliet P. , 1999. Nature Medicine, 5 pp. 1135-1142.
ici le détail